{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:53:37Z","timestamp":1780563217002,"version":"3.54.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115303"],"award-info":[{"award-number":["115303"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218258","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T17:42:45Z","timestamp":1560447765000},"page":"e0218258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-008X","authenticated-orcid":true,"given":"Delphine","family":"Bachelet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-2792","authenticated-orcid":true,"given":"Thilo","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyprien","family":"Mbogning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"H\u00e4ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schultze-Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Repess\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Rayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-3424","authenticated-orcid":true,"given":"Behnaz","family":"Pezeshkpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Liphardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Hincelin-M\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"D\u00f6nnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lacroix-Desmazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"K\u00f6nigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bro\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ABIRISK consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/2040620712464509","article-title":"Factor VIII inhibitors in hemophilia A: rationale and latest evidence","volume":"4","author":"C Witmer","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A","volume":"374","author":"F Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A","volume":"7","author":"A Pavlova","year":"2009","journal-title":"J Thromb Haemost JTH"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood-2012-06-434803","article-title":"The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort","volume":"121","author":"J Astermark","year":"2013","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1655945","article-title":"HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII","volume":"77","author":"J Oldenburg","year":"1997","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1655944","article-title":"HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party","volume":"77","author":"CR Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1111\/j.1365-2516.2011.02604.x","article-title":"Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the south of Brazil","volume":"18","author":"MF De Barros","year":"2012","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"ref8","article-title":"Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A","author":"H Pergantou","year":"2013","journal-title":"Haemophilia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2005-09-3918","article-title":"Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A","volume":"107","author":"J Astermark","year":"2006","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2516.2010.02473.x","article-title":"A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A","volume":"17","author":"JN Lozier","year":"2011","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2516.2012.02845.x","article-title":"Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients","volume":"18","author":"P Pinto","year":"2012","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2006-05-024711","article-title":"Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A","volume":"108","author":"J Astermark","year":"2006","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1538-7836.2007.02290.x","article-title":"Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A","volume":"5","author":"J Astermark","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref14","article-title":"Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphism in the HMOX1 promoter","author":"Y Repess\u00e9","year":"2013","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/jth.12631","article-title":"The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A","volume":"12","author":"CL Eckhardt","year":"2014","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1538-7836.2008.03187.x","article-title":"Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice","volume":"6","author":"PC ter Avest","year":"2008","journal-title":"J Thromb Haemost JTH"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/hae.12566","article-title":"Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A","volume":"21","author":"SM Hashemi","year":"2015","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/hae.12778","article-title":"Classification and regression tree analysis vs. multivariable linear and logistic regression methods as statistical tools for studying haemophilia","volume":"21","author":"S Henrard","year":"2015","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1399-0039.2001.057002144.x","article-title":"HLA class II associations with Type 1 diabetes mellitus: a multivariate approach","volume":"57","author":"RF Schipper","year":"2001","journal-title":"Tissue Antigens"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH14-09-0789","article-title":"Danger signal-dependent activation of human dendritic cells by plasma-derived factor VIII products","volume":"114","author":"L Miller","year":"2015","journal-title":"Thromb Haemost"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004390050480","article-title":"Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease","volume":"100","author":"T Kimpara","year":"1997","journal-title":"Hum Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1479-5876-8-68","article-title":"Effective knowledge management in translational medicine","volume":"8","author":"S Szalma","year":"2010","journal-title":"J Transl Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2043-9113-4-6","article-title":"A novel tree-based procedure for deciphering the genomic spectrum of clinical disease entities","volume":"4","author":"C Mbogning","year":"2014","journal-title":"J Clin Bioinforma"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000380850","article-title":"A Bagged, Partially Linear, Tree-Based Regression Procedure for Prediction and Variable Selection","volume":"79","author":"C Mbogning","year":"2015","journal-title":"Hum Hered"},{"key":"ref25","unstructured":"Mbogning, C W T. GPLTR: Generalized Partially Linear Tree-Based Regression Model. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/Cran.Rproject.Org\/Web\/Packages\/GPLTR\/\" xlink:type=\"simple\">http0:\/\/Cran.Rproject.Org\/Web\/Packages\/GPLTR\/<\/ext-link>: 2014."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y","article-title":"Polymorphic haplotypes of the interleukin-10 5\u2019 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis","volume":"42","author":"E Crawley","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref27","first-page":"69","article-title":"Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients","volume":"43","author":"M Franchini","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2006-05-022756","article-title":"VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors","volume":"109","author":"S Dasgupta","year":"2007","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:25:48Z","timestamp":1589034348000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218258"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Garcia de Frutos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]}}}